These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6851627)

  • 21. Management of dyslipidemia.
    Akel MM; Salti I
    J Med Liban; 2001; 49(5):274-8. PubMed ID: 12243421
    [No Abstract]   [Full Text] [Related]  

  • 22. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The lowering of serum cholesterol in the prevention of coronary disease (part 1). The Canadian Study Group for Periodic Medical Examinations].
    Union Med Can; 1994 Apr; 123(4):249-58. PubMed ID: 8203048
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug therapy of hyperlipidemias].
    Wolfram G
    Wien Med Wochenschr; 1981; 131(13-14):333-8. PubMed ID: 7281700
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of hyperlipidemia: an update.
    Keller KB; Lemberg L
    Heart Lung; 1990 May; 19(3):317-20. PubMed ID: 2341269
    [No Abstract]   [Full Text] [Related]  

  • 26. Achieving lipid goals in Europe: how large is the treatment gap?
    Schwandt P; Brady AJ
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):431-49. PubMed ID: 15151488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Should lipid-lowering drugs be administered to normolipemic or mild hyperlipemic patients with coronary risk factors? Arguments for].
    de Teresa Galván E; Jiménez Navarro M
    Rev Esp Cardiol; 1996 Jul; 49(7):483-5. PubMed ID: 8754441
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia.
    Svilaas A; Strandberg T; Eriksson M; Hildebrandt P; Westheim A
    Scand Cardiovasc J; 2008 Aug; 42(4):279-87. PubMed ID: 18609053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A vote of no confidence in the precision of the estimated cost-effectiveness of lipid lowering.
    Wilcock M
    Br J Gen Pract; 2000 Nov; 50(460):917-8. PubMed ID: 11141882
    [No Abstract]   [Full Text] [Related]  

  • 30. Dyslipidemia and coronary heart disease: management issues from Indian perspective.
    Gambhir DS; Gambhir JK; Sudha R
    Indian Heart J; 2000; 52(5):515-6, 617. PubMed ID: 11256772
    [No Abstract]   [Full Text] [Related]  

  • 31. Statins as the cornerstone of drug therapy for dyslipidemia: monotherapy and combination therapy options.
    Jones PH
    Am Heart J; 2004 Jul; 148(1 Suppl):S9-13. PubMed ID: 15211327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoting adherence to low-fat, low-cholesterol diets: review and recommendations.
    McCann BS; Retzlaff BM; Dowdy AA; Walden CE; Knopp RH
    J Am Diet Assoc; 1990 Oct; 90(10):1408-14, 1017. PubMed ID: 2212424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Should lipid-lowering drugs be administered to normolipemic or mild hyperlipemic patients with coronary risk factors? Arguments against].
    Brotons Cuixart C; Maiques Galán A
    Rev Esp Cardiol; 1996 Jul; 49(7):486-91. PubMed ID: 8754442
    [No Abstract]   [Full Text] [Related]  

  • 35. Combination therapy for dyslipidemia.
    Spellman CW
    J Am Osteopath Assoc; 2003 Jan; 103(1 Suppl 1):S9-11. PubMed ID: 12572624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy of lipid metabolism disorders].
    Schlierf G
    Internist (Berl); 1984 May; 25(5):275-81. PubMed ID: 6329983
    [No Abstract]   [Full Text] [Related]  

  • 37. [Role of lipemia-lowering agents in the secondary prevention of myocardial infarct].
    Tullio D
    Clin Ter; 1986 Feb; 116(3):221-35. PubMed ID: 3516543
    [No Abstract]   [Full Text] [Related]  

  • 38. [Lipid reduction--a pressing problem. Attention to risk patients-- in addition to diet, selection of appropriate drugs].
    Bethcke B
    Fortschr Med; 1988 Aug; 106(25):51. PubMed ID: 3169673
    [No Abstract]   [Full Text] [Related]  

  • 39. [Arteriosclerosis. IV. Treatment of dyslipoproteinemia].
    Cybulska B; Kłosiewicz-Latoszek L
    Wiad Lek; 1985 Sep; 38(17):1251-7. PubMed ID: 4090499
    [No Abstract]   [Full Text] [Related]  

  • 40. Are the massive diet fat-heart and coronary drug studies justified? A critical commentary.
    Roberts HJ
    Angiology; 1968 Dec; 19(12):652-64. PubMed ID: 4882422
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.